Global Asset Management Group, Inc. (GAMG): M&A transaction — Kenilworth Systems acquires 60% of Regenecell in share exchange; Swank joins board

Global Asset Management Group, Inc.

KENS issued 2M shares to Steven Swank for 600k shares of Regenecell, gaining 60% control.
Regenecell net loss $45,872 on $31k revenue for June-Sept 2023; auditor notes going concern doubt.
Pro forma combined net loss $26,724; KENS shareholders' deficit ~$72k post-acquisition.
Steven Swank, 83, appointed Director and Secretary effective Sept 30, 2023.
Regenecell provides medical travel consulting; Swank retains 40% minority interest.

item 2.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Steven Swank

Director and Secretary

GAMG · Global Asset Management Group, Inc.

Effective: 2023-09-30
Filed: October 5, 2023, 7:59 PM ET

On September 30, 2023, Steven Swank was appointed as a Director and Secretary of the Company following the acquisition by the Company of a 60% controlling interest in Regenecell, Inc., a Company of which Mr. Swank was the President and Founder.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Swank was appointed as Director and Secretary at Global Asset Management Group, Inc..

Action: appointed
Role: Director and Secretary

Exact text from the filing

On September 30, 2023, Steven Swank was appointed as a Director and Secretary of the Company following the acquisition by the Company of a 60% controlling interest in Regenecell, Inc., a Company of which Mr. Swank was the President and Founder.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Global Asset Management Group, Inc. completed an acquisition involving Regenecell, Inc. (closed 2023-09-30).

Action: acquisition
Counterparty: Regenecell, Inc.
Closing: 2023-09-30

Exact text from the filing

On September 30, 2023, the Company completed a Share Exchange in which it acquired a 60% controlling equity interest in Regenecell, Inc., a Florida corporation which has been newly-formed and is engaged in the business of medical travel consulting and referral services.

View on SEC.gov

Browse all m&a transactions →

Global Asset Management Group, Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-007399

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.